Regeneration-Associated Genes: A Historical Perspective
=======================================================

The extent to which neurons can regenerate injured axons varies dramatically in the adult mammalian nervous system. Axotomy of peripheral neurons results in the activation of hundreds of neuron-intrinsic regeneration-associated genes (RAGs), whereas in many central neurons a very limited or no RAG-response is observed, except following very proximal lesions (Jenkins et al., [@B25]; Fernandes et al., [@B16]; Mason et al., [@B35]). In addition to the inhibitory extracellular environment of the CNS, the absence of a coordinated RAG-response is a major reason for regenerative failure in the CNS. Early findings that particular axonal proteins, such as GAP-43 and alpha-tubulin, are induced in injured peripheral neurons led to the hypothesis that peripheral nerve injury triggers an intrinsic cell body response that includes the expression of a set of growth-associated proteins (GAPs) that together promote axon regeneration (Skene and Willard, [@B53]; Skene, [@B52]; Tetzlaff et al., [@B62]).

The idea that successful regeneration of injured axons also requires an appropriate intrinsic RAG-response is further supported by several other observations. Firstly, although CNS neurons do not regenerate spontaneously, if a peripheral nerve graft is implanted into the spinal cord, some spinal neurons (on average 100--200 per animal), actually can regenerate injured axons into the graft (David and Aguayo, [@B13]; Richardson et al., [@B47]), indicating that certain central neurons do have the intrinsic capacity to regenerate injured axons when provided with a suitable growth-stimulating environment. CNS neurons that are able to regenerate into nerve grafts also upregulate RAGs following axotomy (Anderson et al., [@B3]; Mason et al., [@B36]). It is important to note, however, that most injured neurons in the spinal cord do not show such a response, and that the majority of neurons that do are located very close to the lesion site. Secondly, treatment of rubrospinal neurons with BDNF at their cell bodies results in upregulation of GAP expression and promotes regeneration of axons into peripheral nerve transplants in the spinal cord (Kobayashi et al., [@B27]), even when neurons are chronically lesioned and severely atrophied (Kwon et al., [@B29]). Thus, exogenous treatments that boost RAG expression in these neurons also increase the number of regeneration-competent cells. Thirdly, when dorsal root ganglion (DRG) neurons are conditioned by a peripheral nerve transection, a lesion which induces RAG expression, their central axons show an enhanced regenerative response that can result in significant sprouting into the spinal cord, even beyond the lesion site (Richardson and Issa, [@B46]; Chong et al., [@B11]; Neumann and Woolf, [@B41]). Finally, this conditioning lesion effect was shown to be transcription dependent (Smith and Skene, [@B54]). Together these findings all indicate that a coordinated neuron-intrinsic regeneration-associated transcriptional response is critical for successful axonal regeneration to occur, and are in support of the RAG-hypothesis.

By now, genome-wide gene expression profiling studies have provided a near-complete view of the complex changes in neuronal gene expression in diverse PNS and CNS injury paradigms (Costigan et al., [@B12]; Xiao et al., [@B66]; Schmitt et al., [@B48]; Kury et al., [@B28]; Di Giovanni et al., [@B14]; Bosse et al., [@B9]; Stam et al., [@B57]; Geeven et al., [@B18]). Meta-analyses of these transcriptional profiling studies revealed the core set of RAGs that is consistently upregulated following neuronal injury (Szpara et al., [@B61]; Stam et al., [@B58]). These studies have further supported the original RAG-hypothesis by showing that many genes are strongly upregulated during successful regeneration, whereas types of injury (e.g., dorsal root injury) that are not followed by successful regeneration, do not robustly induce their expression.

The identification of RAGs led to the idea that axon regeneration could be promoted by manipulating the expression of specific RAGs in injured neurons. Initial studies using transgenic GAP-43 mice were promising and showed an enhancement of long-distance regenerative axon growth in the PNS (Aigner et al., [@B1]). In the CNS, however, overexpression of GAP-43 only induced nerve sprouting, but failed to induce long-distance regeneration (Aigner et al., [@B1]; Buffo et al., [@B10]; Neumann and Woolf, [@B41]), even into growth-permissive peripheral nerve grafts (Mason et al., [@B33]). Also, GAP-43 knockout mice have no gross axonal growth deficits, but show profound defects in axonal guidance (Strittmatter et al., [@B60]; Sretavan and Kruger, [@B56]; Maier et al., [@B32]; Zhu and Julien, [@B67]). Other classical RAGs that have only limited effects on axon regeneration include *Sprr*1*a* and *Itga*7 (Werner et al., [@B65]; Bonilla et al., [@B8]; Raivich et al., [@B45]). These findings demonstrate that manipulating the expression of individual RAGs does not induce robust axon regeneration in the CNS, and therefore research started to focus on transcriptional regulators that can affect the expression of multiple RAGs jointly.

The RAG Regulatory Network: Regeneration-Associated Transcription Factors
=========================================================================

All cellular processes are controlled by genes that act together in regulatory networks. Gene regulatory networks are inherently robust against random perturbation (Albert et al., [@B2]), which may explain why manipulating the expression of individual RAGs has a limited effect on axon regeneration. One way to alter the state of the network is to jointly manipulate the expression of multiple genes in the network. Indeed, overexpression of both *Gap*-43 and *Cap*23 in the RAG network resulted in enhanced DRG regeneration into peripheral nerve grafts implanted in the spinal cord (Bomze et al., [@B7]). There are however practical limitations to the number of RAGs that can be simultaneously overexpressed. As an alternative, one could change the expression of so-called hub genes in the RAG network. Hub genes are highly connected nodes in a gene network and regulate the coordinated expression or activity of many other genes. They are therefore attractive candidate targets for perturbation at the network level (Batada et al., [@B4]; Figure [1](#F1){ref-type="fig"}).

![**General structure of gene networks**. **(A)** Typical example of a gene network. Highly connected genes (indicated in red) are referred to as hub genes. **(B)** Gene networks, like most other biological networks and many non-biological networks too, are scale-free. The connectivity distribution *P*(*k*) in a scale-free network follows an inverse power relation with number of connections *k* per node. Consequently, gene networks contain many nodes with low connectivity (gray part of the curve), whereas only a few nodes are highly connected and qualify as hub genes (red part of the curve). Scale-free networks are robust against random perturbation. This protects gene networks from falling apart as a result of random mutations, but it is at the same time the Achilles' heel of a gene network because targeted attacks at network hubs will quickly result in network fragmentation and deregulation of large groups of genes. Hub genes are therefore interesting candidate targets to efficiently interfere with cellular function.](fnmol-04-00046-g001){#F1}

Hubs in gene regulatory networks are often transcription factors (TFs). C-JUN was the first TF to be identified in the RAG network (Herdegen et al., [@B21]; Jenkins and Hunt, [@B24]), and plays an important role in the successful regeneration of facial nerve motor neurons (Raivich et al., [@B45]). Later, additional regeneration-associated TFs were identified, including ATF3, SOX11, CREB, p53, STAT3, KLF4, and SMAD1 (Schwaiger et al., [@B49]; Tsujino et al., [@B64]; Gao et al., [@B17]; Di Giovanni et al., [@B15]; Jankowski et al., [@B23]; Seijffers et al., [@B50]; Moore et al., [@B40]; Zou et al., [@B68]). Some of these TFs are now recognized as important regulators of specific subsets of RAGs. For instance, C-JUN induces expression of *Itga*7 (with *Itgb*1 the receptor for laminin), the cell adhesion molecule *Cd*44, and the neuropeptide *Gal* (Raivich et al., [@B45]), and ATF3 induces expression of *c-Jun*, the heat-shock protein *Hsp*27 and *Sprr*1*a* (a marker specific for regenerative axon growth; Seijffers et al., [@B51]). The key question now is: which of these TFs are actual network hubs that can be targeted successfully to "reprogram" injured neurons so that they acquire a RAG network that enhances the rate of regeneration of injured central neurons?

We and others recently addressed this question using a combination of various experimental and biocomputational approaches (Macgillavry et al., [@B31], [@B30]; Michaelevski et al., [@B39]; Geeven et al., [@B18]). First, we used medium-throughput cellular screening to test the effects of 62 candidate regeneration-associated TFs on axon growth *in vitro*. Each of these 62 TFs was previously found to be differentially regulated in peripherally injured DRG neurons compared with centrally injured DRG neurons (Stam et al., [@B57]), however, only 10 affected axon growth after knockdown in a DRG-like cell line (Macgillavry et al., [@B31]). Importantly, there was a discrepancy between the direction of regulation and the observed effects upon knockdown for several of these TFs. In particular one TF, NFIL3, was strongly upregulated during successful regeneration, but reducing its expression significantly enhanced axon growth (Macgillavry et al., [@B31]). This rather paradoxical finding is further discussed below. We also developed and used a computational approach to predict TFs that bind to and regulate the expression of RAGs. Using this approach, we identified several novel TFs whose expression levels are not changed upon injury, but that are predicted to affect the coordinated expression of multiple RAGs sharing similar functions (Geeven et al., [@B18]). One of these TFs, PPAR gamma, was shown to repress the expression of several axon growth-inhibiting genes, and may be involved in fatty acid signaling from the injury site to the nucleus of the injured neurons (Geeven et al., [@B18]). Together, these two approaches have helped to identify novel candidate TFs in the RAG network. In a related study, Michaelevski et al. ([@B39]) combined gene expression profiling with phosphoproteome analysis of retrograde injury signals derived from axoplasm and *in silico* promoter-binding analysis, and they were able to identify many novel regeneration-associated TFs in DRG neurons. Further signaling network analysis led them to identify four protein kinases that may act as central regulators of these transcriptional pathways. Manipulation of these kinases by pharmacological inhibition had some effect on neurite outgrowth *in vitro*, but these effects were largely non-additive, which the authors took to be indicative of the robustness of the RAG network.

Not all RAGs Promote Axon Regeneration: Evolutionary Constraints on the Network
===============================================================================

We were intrigued by the fact that NFIL3 is upregulated in DRG sensory neurons by peripheral nerve injury (Stam et al., [@B57]), but that suppressing NFIL3 expression strongly enhances axon growth of cultured adult DRG neurons (Macgillavry et al., [@B31]). The relation between the injury-induced expression of a TF and its apparent role in regeneration can indeed be quite paradoxical, and at least three other studies have shown examples of RAGs that repress axon growth. SOCS3, for instance, is induced in DRG neurons by a peripheral nerve lesion, but represses axon growth by inhibiting the growth-promoting TF STAT3 (Miao et al., [@B38]). The regeneration-promoting effects of cAMP on injured retinal ganglion cells appear to be mediated by a downregulation of SOCS3 (Park et al., [@B44]). Genetic deletion of SOCS3 promotes optic nerve regeneration (Smith et al., [@B55]), whereas overexpression of SOCS3 inhibits optic nerve regeneration (Hellstrom et al., [@B20]). Another study demonstrated that NFAT-3 is a transcriptional repressor of *Gap*-43 expression (Nguyen et al., [@B42]). This was unexpected, as it is long known that NFATs are activated in response to growth factors and mediate axon growth and pre-synaptic differentiation (Graef et al., [@B19]). Finally, KLF4 was identified as a repressor of axon growth (Moore et al., [@B40]; Blackmore et al., [@B5]). Although KLF4 expression is not upregulated after injury (Szpara et al., [@B61]; Stam et al., [@B58]), *in vivo* deletion of KLF4 does enhance optic nerve regeneration (Moore et al., [@B40]). Moreover, the same study showed that several other KLF family members also suppress axon growth, while two others, KLF6 and KLF7, promote axon growth.

In an attempt to understand the role of NFIL3 in the RAG regulatory network, we further studied how NFIL3 regulates RAG expression. We showed that NFIL3 expression follows cAMP induction and CREB activation, and that NFIL3 suppresses CREB target genes such as *Arg*1 and *Gap*-43, by competing for the same DNA binding sites (Macgillavry et al., [@B31]; Figure [2](#F2){ref-type="fig"}). Such so-called incoherent feed-forward loops occur in many other gene regulatory networks, and allow efficient control of target gene dynamics (Kaplan et al., [@B26]). CREB and NFIL3 are widely expressed in the brain, and their feed-forward interactions may have evolved to create strict temporal control over the expression of plasticity genes. In a subsequent study, we identified C/EBP TFs as part of this regulatory loop. CREB induces C/EBP expression in neurons, and NFIL3 also suppresses many C/EBP target genes (Macgillavry et al., [@B30]; Figure [2](#F2){ref-type="fig"}). Together, these findings for the first time reveal a part of the gene regulatory network architecture underlying neuronal regeneration, and suggest that genetic mechanisms to fine-tune neuronal plasticity form an evolutionary constraint on a neuron's ability to regenerate injured axons.

![**A gene network for neuronal regeneration**. Induction of cAMP levels and subsequent activation of CREB play an important role in starting up a RAG-response in injured neurons. We showed that one of the targets of CREB is another TF named NFIL3, and that NFIL3 functions as a feed-forward repressor of several CREB target genes (e.g., *Arg*1 and *Gap*-43). In another study, we identified a set of RAGs (i.e., *Itg*7*a*, *Creb*3*l*2, *Mtl*5, *Bid*, *Snip*1, *Syn*1, *Fmr*1, *Drd*4) that are activated by C/EBP TFs, which are known downstream targets of CREB, and we showed that these RAGs are also repressed by NFIL3. We thus characterized a small part of the gene network that controls neuronal regeneration, and identified CREB, C/EBP, and NFIL3 as hub genes in this network. Downregulation of NFIL3 in neuronal cell lines or in adult primary DRG neurons significantly enhanced their regenerative capacity.](fnmol-04-00046-g002){#F2}

RAG Network Hubs: Therapeutic Perspective
=========================================

Insights into RAG network architecture, and the identification of hub TFs within the network, may aid the future development of gene therapeutic and pharmacological strategies to enhance the intrinsic regenerative potential of injured central neurons. Although direct translation of current knowledge into clinically relevant therapeutic approaches is not possible yet, we are tempted to make some predictions. NFIL3, for instance, is widely expressed in the CNS, and may serve to suppress or fine-tune CREB-dependent plasticity. If NFIL3 indeed also represses regenerative axon growth in the CNS, then our findings would predict that a transient relief of NFIL3-mediated repression might temporarily enhance the effects of CREB and stimulate axonal regeneration. Gene therapy is an ideal method to deliver or inactivate hub TFs, as it can selectively target the desired neurons and allows simultaneous overexpression of growth-promoting TFs and suppression of growth-inhibiting TFs, at least for pre-clinical studies. We, and others, have explored the use of vectors based on lentivirus and adeno-associated virus (AAV) for gene delivery to the nervous system. AAV vectors are highly effective for gene delivery to DRG neurons and rubrospinal neurons (Hollis et al., [@B22]; Blits et al., [@B6]; Mason et al., [@B34]; Parikh et al., [@B43]; Figure [3](#F3){ref-type="fig"}). AAV vectors are also promising as vectors that can be delivered via the CSF intrathecally (Storek et al., [@B59]; Towne et al., [@B63]), although such an untargeted delivery method may be unsuitable when the intervention is required only in specific neuronal populations.

![**Gene therapy to promote regeneration in the spinal cord**. **(A)** Schematic diagram of how AAV vectors might be used to promote regeneration of ascending dorsal column axons. One or more AAV5 vectors expressing key hub TFs are injected into the DRG. These TFs induce RAG expression in the transduced neurons. **(B)** Expression of GFP in an L5 DRG 12 weeks after injection of AAV5-CMV-GFP. Almost the entire neuronal population is transduced. Green: GFP; Red: βIII tubulin.](fnmol-04-00046-g003){#F3}

A major challenge is how to regulate gene expression so that it can be turned off when no longer required, whether this is days or months after application of the vector (Mason et al., [@B37]), as a continued growth response may eventually have undesirable consequences. Other developments will include the methods to deliver multiple transgenes simultaneously to the same neuron, for example using AAV vectors with multiple promoters. AAV vectors in particular, hold great promise as clinically acceptable gene therapy vectors for the promotion of CNS regeneration since they have proven to be well-tolerated and safe in patients.

Concluding Remarks
==================

Hub TFs in the RAG regulatory network provide an attractive class of molecular targets for promoting the regenerative capacity of injured neurons because they jointly regulate the expression of many RAGs simultaneously. Interestingly, recent studies into RAG network architecture showed that some regeneration-associated TFs actually suppress the regenerative capacity of neurons. Such intrinsic inhibitors of neuronal regeneration may provide interesting targets to inactivate using viral vector approaches. Ideally, the combined expression and/or inactivation of a few hub TFs in the RAG network will be sufficient to enhance the regeneration of axotomized central neurons, and we expect that further elucidation of RAG network architecture will aid the selection of therapeutically relevant TF targets in the future.
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